Crohn’s disease (CD) is a clinical condition characterized by inflammation of the intestines that may involve the entire thickness of the intestinal walls. CD most often involves the small intestine and colon. Over the past decades, intestinal adenocarcinoma has been recognized as a complication of CD. The management of patients with peritoneal metastasis (PM) of small bowel adenocarcinoma (SBA) associated with Crohn’s disease (CD) has not been defned yet. This report will be structured as a case report of PM of SBA associated with CD. From this data, other peritoneal surface oncology centers may wish to offer CRS and HIPEC to patients with similar features at early stages of this disease.